SAN DIEGO — Medical Marijuana, Inc.’s (OTC Pink:MJNA) is proud to inform shareholders and the public that today the Health Department of Mexico, COFEPRIS, issued the country’s first-ever government permits to import cannabidiol (CBD) hemp oil.
One of the permits is granted to 11 Year-Old Alina Maldonado Montes de Oca whose father, Abelardo Maldonado Constantino, drove eight hours – one way – by bus to pick up the historic document. These are the first import permits in Mexico’s history allowing importation of non-psychoactive cannabis oil / cannabidiol (CBD) hemp oil. The brand of CBD hemp oil that Alina and Maria Paula are accessing is RSHO-X by Medical Marijuana, Inc., as stated by the Mexican government agency COFEPRIS.
“We would like to express our appreciation for the government of Mexico, in particular COFEPRIS, that took the time to understand the need for Alina’s and Maria Paula’s access to RSHO-X cannabidiol (CBD) hemp oil,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “Their permits signify a new chapter in world history and an epic change in Mexico’s cannabis laws. All others in Mexico wishing to access CBD hemp oil may now do so, according to the government health agency’s statement issued today.”
Details of the COFEPRIS announcement can be found here: http://www.cofepris.gob.mx/Documents/NotasPrincipales/01022016.pdf
Additional information is listed on the HempMeds® Mexico website.
The cannabis movement is quickly progressing in Mexico and kicked-off with a series of Congressional hearings on Monday, January 25th where HempMeds® Mexico, General Hemp, Dr. Bronner’s Mexico, Heaven Grown, Be Hemp and Cañamo Magazine along with the Por Grace Foundation rallied at an historic event in Mexico City called, “Medical Cannabis In Mexico: Experiences and Perspectives”.
The educational event was hosted by HempMeds® Mexico’s premier charitable partner, the “Por Grace Foundation.” The Foundation’s goal is to make sure Mexican families receive the right to health care, and inform parents with children whose lives could be dramatically impacted by CBD hemp oil. Nearly 200 families attended the Mexico City event. Some of the keynote speakers include a highly respected neurologist in Mexico City, Dr. Saul Garza Morales, and Medical Marijuana, Inc.’s Chief Executive Officer, Stuart W. Titus, PhD.
“It is a tremendous honor for both Medical Marijuana, Inc. and HempMeds® Mexico to be the pioneers for the cannabis revolution taking place in Mexico,” concludes Dr. Titus.
Medical Marijuana, Inc. and HempMeds® will participate in more educational symposiums. For more information on RSHO-X, visit http://www.hempmeds.mx
About HempMeds® Mexico
HempMeds® Mexico is a Mexico-based company, created to provide access to cannabinoid-based products including cannabidiol (CBD) hemp oil products as they become legal in the country of Mexico for the first time. Our Company is a sales, marketing and distribution company. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to our CBD hemp oil products. HempMeds® Mexico is the first company to legally ship RSHO-X CBD hemp oil into Mexico. For more information, please review the company’s website at: http://hempmeds.mx/.
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
The mission of Medical Marijuana, Inc. (OTC Pink:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
The photos are also available at Newscom, www.newscom.com, and via AP PhotoExpress.
For further information, please contact: Public Relations contact: Andrew Hard Chief Executive Officer CMW Media P. 888-829-0070 email@example.com www.cmwmedia.com Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc